3 recruiting. 3 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Recruiting 3 |
| Phase 1 | 1 | Recruiting 1 |
Follow Malignant Digestive System Neoplasm: new trials by email Literature Review of Malignant Digestive System Neoplasm trials Research Report on Malignant Digestive System Neoplasm
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Vasodilator Therapy With Isosorbide Mononitrate or Diltiazem to Reduce Vasotoxicity in Patients With Gastrointestinal Cancer Receiving Fluoropyrimidine Therapy Biospecimen Collection, Capecitabine, Diltiazem Hydrochloride - Malignant Digestive System Neoplasm | Phase 1 / Phase 2 | Recruiting | Mayo Clinic | 60 | 2026-04-30 | 2026-06-02 |
| Fucoidan for Preventing Chemotherapy-Related Fatigue in Patients With Gastrointestinal, Gynecological, Breast, or Lung Cancer Biospecimen Collection, Oligo-fucoidan, Placebo Administration - Malignant Digestive System Neoplasm, Malignant Female Reproductive System Neoplasm | Phase 2 | Recruiting | Mayo Clinic | 34 | 2025-03-06 | 2026-10-16 |
| 2 Versus 6 Hour Oxaliplatin Infusions in Patients With Gastrointestinal Cancers Fluorouracil, Leucovorin, Oxaliplatin - Malignant Digestive System Neoplasm | Phase 2 | Recruiting | Emory University | 60 | 2019-03-14 | 2025-11-06 |
Gastrointestinal Neoplasms (3) · Breast Neoplasms (1) · Lung Neoplasms (1)
Digestive System Diseases (3) · Digestive System Neoplasms (3) · Gastrointestinal Diseases (3) · Neoplasms (3) · Neoplasms by Site (3) · Breast Diseases (1) · Lung Diseases (1) · Respiratory Tract Diseases (1) · Respiratory Tract Neoplasms (1) · Skin Diseases (1) · Skin and Connective Tissue Diseases (1) · Thoracic Neoplasms (1)
Fluorouracil (2) · Specimen Handling (2) · Capecitabine (1) · Diltiazem (1) · Electrocardiography, Ambulatory (1) · Isosorbide (1) · Leucovorin (1) · Oxaliplatin (1) · dehydroftorafur (1) · isosorbide-5-mononitrate (1)
Mayo Clinic (2) · Emory University (1)
United States (3)
Joerg Herrmann, MD (1) · Olumide B. Gbolahan, MBBS, MSc (1) · Zoey I. Harris, MD (1)